Skip to content

Study · Non-randomized trial · 2017

1 result

[Сlinical and physiological characteristics and therapy asthenic disorders in adolescents girls].

Rodionova EY, Chutko LS, Surushkina SY, Yakovenko EA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2017Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In adolescent girls with neurasthenia, Cortexin treatment improved clinical condition in 80% of cases.

    In plain wordsIn adolescent girls with neurasthenia, clinical condition improved in 80% of cases after Cortexin treatment.

    Outcome
    IncreaseOverall clinical improvement
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Clinical improvement
    80%
    Cortexin-treated cases

    Source sentences

    Summary
    Treatment with cortexin improved patient's condition in 80% of cases that was supported by the positive EG dynamics.
    1 context sentence
    Summary · context
    Seventy-five women, aged 14-17 years, who were diagnosed with neurasthenia (ICD-10 F.48.0), were examined.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.